Drugs / Chaigui Longmu Ejiao Paste
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07478328 | Mar 2026 → Mar 2027 expected | ischemic disease | Longhua Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chaigui Longmu Ejiao Paste | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07478328 ↗ |
| Route | Oral | “15 g orally twice daily” NCT07478328 ↗ |